DS-8895 is a monoclonal antibody targeting EphA2. It enables non-invasive measurement of EphA2 expression within tumors in vivo. DS-8895 can be utilized for studies involving advanced solid cancers that are EphA2 positive.
Target:
Ephrin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
